ARCHIVES

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCI Trials Listed

June 25, 2010

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

NCI begins rewrite of cancer center grant guidelines; will allow clinical investigator support. Goal is to implement P30-P50 working group recommendations, simplify guidelines, Karen Antman tells advisory board.

March 19, 2004

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976